Nothing Special   »   [go: up one dir, main page]

CY1120945T1 - Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων - Google Patents

Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων

Info

Publication number
CY1120945T1
CY1120945T1 CY181101057T CY181101057T CY1120945T1 CY 1120945 T1 CY1120945 T1 CY 1120945T1 CY 181101057 T CY181101057 T CY 181101057T CY 181101057 T CY181101057 T CY 181101057T CY 1120945 T1 CY1120945 T1 CY 1120945T1
Authority
CY
Cyprus
Prior art keywords
genetically
genetically modified
receptor mice
modeled cell
creation
Prior art date
Application number
CY181101057T
Other languages
English (en)
Inventor
Lynn Macdonald
Andrew J Murphy
John Mcwhirter
Naxin Tu
Vera Voronina
Cagan Gurer
Karolina Meagher
Sean Stevens
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of CY1120945T1 publication Critical patent/CY1120945T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Η εφεύρεση παρέχει ένα γενετικώς τροποποιημένο τρωκτικό το οποίο περιλαμβάνει στο γονιδίωμα του μη αναδιατεταγμένους μεταβλητούς γονιδιακούς τόπους υποδοχέα Τ κυττάρων, καθώς επίσης μη-ανθρώπινα έμβρυα, κύτταρα και ιστούς που τους περιλαμβάνουν. Παρέχονται επίσης κατασκευάσματα για δημιουργία του εν λόγω γενετικώς τροποποιημένου μη-ανθρώπινου ζώου και μέθοδοι δημιουργίας τους. Διάφορες μέθοδοι χρήσης του γενετικώς τροποποιημένου μη-ανθρώπινου ζώου επίσης παρέχονται.
CY181101057T 2011-10-28 2018-10-16 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων CY1120945T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161552582P 2011-10-28 2011-10-28
US201261621198P 2012-04-06 2012-04-06
US201261700908P 2012-09-14 2012-09-14
PCT/US2012/062065 WO2013063361A1 (en) 2011-10-28 2012-10-26 Genetically modified t cell receptor mice

Publications (1)

Publication Number Publication Date
CY1120945T1 true CY1120945T1 (el) 2019-12-11

Family

ID=47178340

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181101057T CY1120945T1 (el) 2011-10-28 2018-10-16 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων
CY20211100142T CY1123831T1 (el) 2011-10-28 2021-02-19 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20211100142T CY1123831T1 (el) 2011-10-28 2021-02-19 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων

Country Status (25)

Country Link
US (4) US9113616B2 (el)
EP (3) EP3795587A1 (el)
JP (7) JP6254528B2 (el)
KR (5) KR101964776B1 (el)
CN (5) CN104011071B (el)
AU (5) AU2012327204B2 (el)
BR (1) BR112014009203B1 (el)
CA (1) CA2853707A1 (el)
CY (2) CY1120945T1 (el)
DK (2) DK2771357T3 (el)
ES (2) ES2691475T3 (el)
HK (1) HK1198171A1 (el)
HR (2) HRP20181626T1 (el)
HU (1) HUE053444T2 (el)
IL (4) IL305550B1 (el)
IN (1) IN2014CN03890A (el)
LT (2) LT3424947T (el)
MX (1) MX353134B (el)
PL (2) PL2771357T3 (el)
PT (2) PT3424947T (el)
RS (2) RS61455B1 (el)
RU (1) RU2661106C2 (el)
SG (2) SG11201401030WA (el)
SI (2) SI3424947T1 (el)
WO (1) WO2013063361A1 (el)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL305550B1 (en) * 2011-10-28 2024-10-01 Regeneron Pharma Mice with a genetic change in the T cell receptor
US20150073043A1 (en) * 2012-01-19 2015-03-12 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences Use of phosphorylation pathway-related factor in regulating function of regulatory t cell
DK2847335T3 (en) 2012-04-25 2018-08-13 Regeneron Pharma NUCLEASED MEDIUM TARGETING WITH LARGE TARGET VECTORS
GB2508414A (en) * 2012-11-30 2014-06-04 Max Delbrueck Centrum Tumour specific T cell receptors (TCRs)
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
DK2986729T3 (en) 2013-04-16 2018-10-29 Regeneron Pharma TARGETED MODIFICATION OF ROOT THROUGH
BR112016013400B1 (pt) 2013-12-11 2023-02-14 Regeneron Pharmaceuticals, Inc. Método in vitro para modificar um genoma em um lócus genômico de interesse em uma célula pluripotente
TWI681969B (zh) * 2014-01-23 2020-01-11 美商再生元醫藥公司 針對ｐｄ-１的人類抗體
EP3152312B1 (en) * 2014-06-06 2020-02-12 Regeneron Pharmaceuticals, Inc. Methods and compositions for modifying a targeted locus
HUE048677T2 (hu) * 2014-06-19 2020-07-28 Regeneron Pharma Humanizált programozott sejthalál 1 génnel rendelkezõ nem-humán állatok
KR102468108B1 (ko) 2014-06-26 2022-11-18 리제너론 파마슈티칼스 인코포레이티드 표적화된 유전자 변형을 위한 방법 및 그 조성물, 및 사용 방법
SG11201701040XA (en) * 2014-09-19 2017-03-30 Regeneron Pharma Chimeric antigen receptors
WO2016081923A2 (en) 2014-11-21 2016-05-26 Regeneron Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAs
RS61080B1 (sr) * 2014-11-24 2020-12-31 Regeneron Pharma Ne-humane životinje koje eksprimiraju humanizovani cd3 kompleks
US11326184B2 (en) 2014-12-19 2022-05-10 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification through single-step multiple targeting
CA3223798A1 (en) 2015-04-06 2016-10-13 Regeneron Pharmaceuticals, Inc. Humanized t cell mediated immune responses in non-human animals
EP3461337A1 (en) 2015-05-06 2019-04-03 Snipr Technologies Limited Altering microbial populations & modifying microbiota
WO2017087780A1 (en) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
JP2019510503A (ja) * 2016-04-07 2019-04-18 ブルーバード バイオ， インコーポレイテッド キメラ抗原受容体ｔ細胞組成物
EP3440105B1 (en) 2016-04-08 2022-04-27 Immunocore Limited T cell receptors
EP4218408A1 (en) * 2016-06-03 2023-08-02 Regeneron Pharmaceuticals, Inc. Rodents expressing exogenous terminal deoxynucleotidyltransferase
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
US20200171170A1 (en) * 2017-06-16 2020-06-04 Mayo Foundation For Medical Education And Research Materials and methods for increasing immune responses
AU2018345539A1 (en) 2017-10-03 2020-04-16 Editas Medicine, Inc. HPV-specific binding molecules
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
US20210017249A1 (en) * 2018-04-05 2021-01-21 Juno Therapeutics, Inc. Methods of producing cells expressing a recombinant receptor and related compositions
EP3845638A4 (en) * 2018-07-26 2022-05-11 Kyoto University METHOD FOR PRODUCING A CELL INTRODUCED BY A FOREIGN ANTIGEN RECEPTOR GENE
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
AU2020344628A1 (en) * 2019-09-12 2022-04-07 TCR2 Therapeutics Inc. Compositions and methods for TCR reprogramming using fusion proteins
IL293330A (en) 2019-12-02 2022-07-01 Regeneron Pharma mhc ii peptide protein structures and uses thereof
EP4126924A4 (en) * 2020-03-27 2024-04-24 2seventy bio, Inc. T CELL RECEPTORS
CN113684258B (zh) * 2020-05-18 2024-08-20 上海赛比曼生物科技有限公司 用于检测鼠源tcr转基因拷贝数的试剂盒及方法
WO2022212582A1 (en) 2021-03-31 2022-10-06 Regeneron Pharmaceuticals, Inc. Genetically modified mice comprising humanized cellular immune system components with improved diversity of tcrβ repertoire
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
US20240114883A1 (en) * 2022-08-12 2024-04-11 Ingenious Targeting Laboratories Genetically modified non-human having humanized gamma and delta TCR variable genes
WO2024038165A1 (en) 2022-08-18 2024-02-22 Immunocore Ltd T cell receptor fusion proteins specific for mage a4
US20240099279A1 (en) 2022-09-22 2024-03-28 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing components of human cellular immune system

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0663952A4 (en) 1992-09-11 1997-06-11 Univ California TRANSGENIC NON-HUMAN ANIMALS WITH TARGETED INTERRUPTED TRANSDUCTION GENES IN LYMPHOCYTES.
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
CA2246333A1 (en) 1996-03-05 1997-09-12 The Scripps Research Institute Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6320306B1 (en) * 1996-08-05 2001-11-20 Samsung Display Devices Co., Ltd. Shadow mask with porous insulating layer and heavy metal layer
WO1998024893A2 (en) 1996-12-03 1998-06-11 Abgenix, Inc. TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM
AU1023401A (en) 1999-10-12 2001-04-23 Institut Pasteur Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2002047474A1 (fr) 2000-12-13 2002-06-20 Sumitomo Pharmaceuticals Company, Limited Animaux transgeniques exprimant hla-a24 et utilisation de ceux-ci
DK1409646T3 (da) * 2000-12-19 2012-08-06 Altor Bioscience Corp Transgene dyr omfattende et humaniseret immunsystem
FR2827302B1 (fr) 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
PT1421115E (pt) 2001-08-31 2005-07-29 Avidex Ltd Receptor de celulas t soluvel
US20050177884A1 (en) 2001-11-15 2005-08-11 Kirin Beer Kabushiki Kaisha Chimeric nonhuman animal
DE60106469T2 (de) 2001-12-22 2005-10-13 4-Antbody AG Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
IL162111A0 (en) 2001-12-22 2005-11-20 4Antibody Ag Method for the generation of generically modified vertebrate precursor lymphocytes and use thereof for the production of heterologo
DE10244457A1 (de) 2002-09-24 2004-04-01 Johannes-Gutenberg-Universität Mainz Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
US7569664B2 (en) 2002-10-09 2009-08-04 Immunocore Limited Single chain recombinant T cell receptors
WO2004042004A2 (en) * 2002-10-30 2004-05-21 The Wistar Institute Of Anatomy And Biology Mouse model for autoimmune disorders
US7663017B2 (en) 2003-07-30 2010-02-16 Institut Pasteur Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
PT1802193E (pt) 2004-10-19 2014-06-23 Regeneron Pharma Método para gerar um murganho homozigótico para uma modificação genética
US20090304657A1 (en) 2006-05-03 2009-12-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Chimeric t cell receptors and related materials and methods of use
EP1878342A1 (en) * 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
WO2008051854A2 (en) 2006-10-20 2008-05-02 Trustees Of Boston University A tunable genetic switch for regulating gene expression
JP2008159109A (ja) 2006-12-21 2008-07-10 Matsushita Electric Ind Co Ltd データ転送装置
US20090271884A1 (en) 2008-03-07 2009-10-29 Regeneron Pharmaceuticals, Inc. ES Cell-Derived Mice From Diploid Host Embryo Injection
US20090328240A1 (en) 2008-06-24 2009-12-31 Sing George L Genetically modified mice as predictors of immune response
WO2010107400A1 (en) * 2009-03-20 2010-09-23 Agency For Science, Technology And Research Genetically modified animal and method of obtaining the same
DK2564695T3 (en) * 2009-07-08 2015-05-26 Kymab Ltd Animal models and therapeutic molecules
GB0917090D0 (en) 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
US10464987B2 (en) 2009-10-06 2019-11-05 Abbvie Inc. Human single-chain T cell receptors
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
WO2012039779A1 (en) 2010-09-24 2012-03-29 The United States Of America As Represented By The Secretary Of The Navy Humanized transgenic mouse model
CN103348012B (zh) 2010-11-27 2016-06-08 朱坚 一种人源化的转基因动物
IL305550B1 (en) * 2011-10-28 2024-10-01 Regeneron Pharma Mice with a genetic change in the T cell receptor
CA3223798A1 (en) 2015-04-06 2016-10-13 Regeneron Pharmaceuticals, Inc. Humanized t cell mediated immune responses in non-human animals

Also Published As

Publication number Publication date
EP3795587A1 (en) 2021-03-24
IL274914B2 (en) 2024-02-01
KR102148387B1 (ko) 2020-08-26
KR20140077219A (ko) 2014-06-23
PT2771357T (pt) 2018-11-09
EP2771357B1 (en) 2018-07-18
HK1198171A1 (en) 2015-03-13
IL305550B1 (en) 2024-10-01
MX353134B (es) 2017-12-20
RU2661106C2 (ru) 2018-07-11
IL232098B (en) 2020-06-30
PL2771357T3 (pl) 2018-12-31
LT2771357T (lt) 2018-10-25
ES2858978T3 (es) 2021-09-30
ES2691475T3 (es) 2018-11-27
DK2771357T3 (en) 2018-10-29
CN107858333B (zh) 2022-05-27
AU2012327204B2 (en) 2016-01-21
KR20220066197A (ko) 2022-05-23
KR20210133325A (ko) 2021-11-05
AU2016202512A1 (en) 2016-05-12
US9113616B2 (en) 2015-08-25
AU2021203192A1 (en) 2021-06-10
US20160021856A1 (en) 2016-01-28
KR102321909B1 (ko) 2021-11-05
RU2014121160A (ru) 2015-12-10
CN104011071A (zh) 2014-08-27
CN107858333A (zh) 2018-03-30
IL232098A0 (en) 2014-05-28
JP2022093637A (ja) 2022-06-23
HUE053444T2 (hu) 2021-06-28
AU2012327204A1 (en) 2013-05-23
JP2024019646A (ja) 2024-02-09
CN107858332A (zh) 2018-03-30
AU2016202512C1 (en) 2018-10-11
HRP20210256T1 (hr) 2021-04-02
US20220386575A1 (en) 2022-12-08
CY1123831T1 (el) 2022-05-27
AU2021203192B2 (en) 2024-04-11
JP7305840B2 (ja) 2023-07-10
AU2018204700B2 (en) 2021-04-01
US20210051930A1 (en) 2021-02-25
KR102542272B1 (ko) 2023-06-13
JP2014532413A (ja) 2014-12-08
BR112014009203B1 (pt) 2023-02-28
AU2016202512B2 (en) 2018-03-29
WO2013063361A1 (en) 2013-05-02
IL315445A (en) 2024-11-01
JP6706311B2 (ja) 2020-06-03
US11528895B2 (en) 2022-12-20
LT3424947T (lt) 2021-03-10
JP2019033770A (ja) 2019-03-07
SG10201914043XA (en) 2020-03-30
RS61455B1 (sr) 2021-03-31
SG11201401030WA (en) 2014-04-28
NZ623147A (en) 2016-03-31
RS57893B1 (sr) 2019-01-31
SI2771357T1 (sl) 2018-11-30
IL274914B1 (en) 2023-10-01
JP2020146045A (ja) 2020-09-17
IL274914A (en) 2020-07-30
DK3424947T3 (da) 2021-02-22
HRP20181626T1 (hr) 2018-12-14
BR112014009203A2 (pt) 2020-10-27
CA2853707A1 (en) 2013-05-02
JP6532924B2 (ja) 2019-06-19
SI3424947T1 (sl) 2021-04-30
JP2018007696A (ja) 2018-01-18
IN2014CN03890A (el) 2015-10-16
KR20200102001A (ko) 2020-08-28
KR20190037354A (ko) 2019-04-05
KR102397961B1 (ko) 2022-05-13
PT3424947T (pt) 2021-03-01
AU2024204645A1 (en) 2024-08-01
JP2023024744A (ja) 2023-02-16
MX2014004894A (es) 2014-09-12
IL305550A (en) 2023-10-01
AU2018204700C1 (en) 2021-10-14
EP2771357A1 (en) 2014-09-03
PL3424947T3 (pl) 2021-06-14
CN114891797A (zh) 2022-08-12
CN104011071B (zh) 2017-11-07
JP6254528B2 (ja) 2017-12-27
AU2018204700A1 (en) 2018-07-19
EP3424947A1 (en) 2019-01-09
CN114891798A (zh) 2022-08-12
KR101964776B1 (ko) 2019-04-04
US20130109053A1 (en) 2013-05-02
EP3424947B1 (en) 2020-11-25

Similar Documents

Publication Publication Date Title
CY1120945T1 (el) Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων
CY1121869T1 (el) Ποντικοι με γενετικα τροποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
CY1122700T1 (el) Γενετικα τροποποιημενοι ποντικοι εκφραζοντες χιμαιρικα μορια μειζονος συμπλεγματος ιστοσυμβατοτητας (μηc) ii
CY1122036T1 (el) Μη ανθρωπινα ζωα που εκφραζουν αντισωματα τα οποια εχουν μια κοινη ελαφρια αλυσιδα
CY1120845T1 (el) Στοχευομενη τροποποιηση γονιδιωματος αρουραιου
CY1120808T1 (el) Μεθοδοι και συνθεσεις για στοχευμενες γενετικες τροποποιησεις και μεθοδοι χρησης
CY1123714T1 (el) Μη-ανθρωπινα ζωα που εκφραζουν ανθρωποποιημενο cd3 συμπλοκο
CY1122940T1 (el) Μη ανθρωπινα ζωα που εχουν ενα εξανθρωπισμενο γονιδιο προγραμματισμενου κυτταρικου θανατου 1
CY1121738T1 (el) Μεθοδοι και συνθεσεις για στοχευμενη γενετικη τροποποιηση χρησιμοποιωντας συζευγμενα rna-οδηγους
CY1121657T1 (el) Μεθοδοι και συνθεσεις για κατευθυνομενη απο rna τροποποιηση dna στοχου και για κατευθυνομενη απο rna ρυθμιση της μεταγραφης
CY1121405T1 (el) Εξανθρωποποιημενα il-15 ζωα
CY1122386T1 (el) Χιμαιρικος υποδοχεας αντιγονων και μεθοδοι χρησης εξ αυτου
CY1121223T1 (el) Ποντικοι οι οποιοι εκφραζουν ανθρωποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
CY1121410T1 (el) Μη-ανθρωπινα ζωα που εχουν ενα εξανθρωποποιημενο γονιδιο ρυθμιστικης πρωτεϊνης σηματος
CY1122179T1 (el) Μεθοδοι και συνθεσεις για την παραγωγη ή την διατηρηση πολυδυναμων κυτταρων
CY1125029T1 (el) Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων
CY1119893T1 (el) Προϊοντα συζευξης cc-1065 αναλογων και διλειτουργικων συνδετων
CY1120599T1 (el) Αντισωματα ελαφριων αλυσιδων τροποποιημενων με ιστιδινη και γενετικα τροποποιημενα τρωκτικα για τη δημιουργια αυτων
TR201910320T4 (tr) Karaciğer organoidi, kullanımları ve elde edilmesine yönelik kültür yöntemi.
CY1119071T1 (el) Εξανθρωποποιημενα il-7 τρωκτικα
UY34014A (es) Genes sintéticos para expresar proteínas en células de maíz, construcciones, plantas transgénicas, métodos para controlar pestes y composiciones
BR112013018311A2 (pt) sequência de ácido nucleico isolada, receptor de antígeno quimérico isolado, célula t geneticamente modificada, vetor, e, uso de uma célula t geneticamente modificada.
MY175954A (en) Light-sensitive ion-passing molecules
BR112016011003A2 (pt) animal roedor geneticamente modificado, célula tronco embrionária de camundongo, embrião de camundongo, e, métodos para fabricar um animal roedor e para enxertar células humanas em um camundongo
WO2015021298A3 (en) Lincrna-deficient non-human animals